Intelligence

#Diabetes #GLP-1 #Mass spectrometry / NMR #Weight loss

How mass spectrometry is supporting GLP-1 breakthroughs in diabetes care

Kean Woodmansey, Senior Global Market Development Manager, Discovery (DMPK), SCIEX, examines how molecular precision is being enabled in GLP-1 therapies through the use of mass spectrometry. On Diabetes Alert Day in March, professionals across healthcare, research, and pharmaceutical development reflected on the pressing need for improved diabetes detection and treatment. Read More

#Exclusive Content #Trends & Analysis

European Commission President Ursula von der Leyen
#Biotech #Biotech hubs #Europe #European Commission #European Union #Market reporting

Can Europe take the lead on biotech?

With uncertainty across the global financial markets and research community, is it Europe’s time to take the lead on biotech? Diana Turner reports.  While biotech has so far been dominated by the US, since the inauguration of Donald Trump in January 2025, there has been considerable uncertainty, with significant… Read More

#Exclusive Content #Market Reports #Trends & Analysis

#Assays #iPSC #Neuroscience #Preclinical development

10 practical tips for reliable MEA experiments in preclinical neuroscience

Combining human iPSC-derived neurons with multi-electrode array (MEA) assays can provide powerful insights into synaptic connectivity, network dynamics, and functional maturation. However, MEA experiments can be challenging, with small changes in cell culture conditions dramatically impacting results. In this expert Guide, bit.bio’s Field Applications Scientist shares key considerations for improving… Read More

#Resources

#Neuroscience

Guide – 10 Practical Tips for Reliable MEA Experiments in Preclinical Neuroscience

Combining human iPSC-derived neurons with multi-electrode array (MEA) assays can provide powerful insights into synaptic connectivity, network dynamics, and functional maturation. However, MEA experiments can be challenging, with small changes in cell culture conditions dramatically impacting results. In this expert guide, bit.bio’s Field Applications Scientist shares key considerations for improving… Read More

#Guides

Drug Discovery for Anti-Obesity
#Assays #Drug discovery #In vivo #Obesity #Weight loss

Accelerate your weight loss drug discovery

Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss… Read More

#Resources

Seed fund
#Artificial intelligence (AI) #Drug discovery #Genetics / genomics #OutSee #Seed funding #Start-ups

Predictive genomics pioneer OutSee raises £1.8m

OutSee has secured £1.8 ($2.4) million in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.   The funds will support OutSee through the next phase of its growth strategy, with a focus on expanding the company’s in-house… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery

Guide – Accelerate your weight loss drug discovery

Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss… Read More

#Guides

#App note #Artificial intelligence (AI) #Drug discovery #Imaging

Your AI-enhanced solution for viral infectivity analysis

Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the application note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimises reagent use, incubation time, and replicate needs,… Read More

#Resources

#Artificial intelligence (AI) #Investment #Life sciences #NVIDIA #Sofinnova Partners #Start-ups

Collaboration to accelerate European life sciences startups

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has collaborated with NVIDIA to support its portfolio of life sciences startups. The collaboration delivers significant Graphics Processing Unit (GPU) credits to select Sofinnova portfolio companies, effectively giving access to the same computational… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery #eBook #Monoclonal antibodies #Therapeutic Antibodies

The significance of mAbs in drug discovery and development

Monoclonal antibodies (mAbs), thanks to their low toxicity and high specificity, have enjoyed incredible market success across a range of disease categories. This eBook, sponsored by Evotec, examines the challenges, solutions and successes in mAb discovery and development. Download this exclusive eBook to learn more about: The 2025 scientific breakthroughs… Read More

#DDW eBooks #Intelligence

#Drug discovery

Ebook: The significance of mAbs in drug discovery and development

Monoclonal antibodies (mAbs), thanks to their low toxicity and high specificity, have enjoyed incredible market success across a range of disease categories. This eBook, sponsored by Evotec, examines the challenges, solutions and successes in mAb discovery and development. Download this exclusive eBook to learn more about: The 2025 scientific… Read More

#DDW eBooks

#Artificial intelligence (AI)

App Note – Your AI-enhanced solution for viral infectivity analysis

Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the application note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimizes reagent use, incubation time, and replicate needs,… Read More

#App Notes